| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,892 |
7,916 |
$438K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,180 |
3,721 |
$257K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,037 |
949 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
308 |
146 |
$3K |
| 80053 |
Comprehensive metabolic panel |
532 |
491 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,716 |
1,555 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
160 |
150 |
$2K |
| 80061 |
Lipid panel |
281 |
258 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
153 |
140 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
30 |
30 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
252 |
235 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
16 |
12 |
$1K |
| 90756 |
|
45 |
41 |
$363.35 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
115 |
94 |
$259.73 |
| 81003 |
|
42 |
38 |
$77.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
54 |
54 |
$21.38 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
14 |
13 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
28 |
26 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
334 |
289 |
$0.00 |